Intellectual Property

Pryor Cashman Partner Stephen M. Goodman, a member of Pryor Cashman’s Corporate and Intellectual Property Groups, will be a speaker at Life Sciences Summit 2012.

Goodman will speak at the “Business Workshops” sessions of the Summit, which is designed to provide professional guidance to emerging companies and faculty entrepreneurs looking to launch, build and fund a life sciences company. These sessions will identify and explore the critical issues and challenges unique to this industry and vital to value creation for emerging companies. 2012 Business Workshops include:

• Where is the Capital for Early Stage Life Science Companies?
• Working With the FDA: How to Add Value in the Transition From Academic Research to Commercial Development
• Collaboration: Working with Industry and Medical Research Foundations Means Understanding Their Language
• The Current Venture Landscape & Evolving Venture Strategies: Considerations for Management of Emerging Companies
• Insights from Innovative Deals Between Academic Scientists and Pharma
• Academic Drug Discovery: Emerging Models Designed to Advance and De-risk Academic Discoveries